Dr. Jeffrey Velotta

About Dr. Jeffrey Velotta

Dr. Velotta is a top mesothelioma doctor at Kaiser Permanente in Oakland, California. He’s also a clinical assistant surgical professor at the University of California San Francisco School of Medicine and a renowned mesothelioma researcher.

“I currently have ongoing studies pertaining to novel ways to provide better pain relief after thoracic surgery and multimodality treatment of mesothelioma,” Dr. Velotta tells us. His research focuses on novel and minimally invasive lung cancer surgery techniques. 

He researches image-guided surgeries and develops surgery improvements. He also works on mesothelioma treatment center regionalization and multimodal therapy research.

Medical Education & Experience

Associations, Awards & Recognition

• Society of Asian Academic Surgeons Mid-Career Faculty Award, 2025
• UCSF Medicine’s Academy of Medical Educators Excellence in Mentorship Award, 2024
• Reversing Health Disparities in Lung Cancer Research Award, 2023
• American College of Surgeons 
• Society of Thoracic Surgeons

Why Choose Dr. Jeffrey Velotta for Pleural Mesothelioma 

Thoracic surgeon Dr. Jeffrey Velotta is paving the way for mesothelioma surgery advancements at Kaiser Permanente Oakland Medical Center. He has years of experience in cardiac and thoracic surgery. His dedication has garnered recognition through several awards for his research and mentorship. 

Velotta’s work focuses on minimally invasive lung and esophageal surgery, image-guided surgical techniques for small lung nodules and multimodality mesothelioma care. He remains committed to providing excellent care and the best surgical services for mesothelioma patients.

Close Button

Full Name

Diagnosis Please Select Mesothelioma Asbestosis Lung Cancer No Diagnosis Other Unknown

Zip Code

Email

Phone Number

Preferred Method of Contact Please Select Call Text

Message

Full Name

By submitting, you agree to our privacy policy and terms of service. Our Patient Advocates may contact you via phone, email and/or text.

Get Connected Now

Publications of Dr. Jeffrey Velotta

• Yang, M.Z. et al. (2024, September 16). Representativeness of Patients With Lung Cancer in an Integrated Health Care Delivery System.
• Banks, C.K. et al. (2022, January 28). Salvage Resection After Immunotherapy in Refractory Malignant Pleural Mesothelioma.
• Okabe, K. et al. (2021, October 1). The Results of Multimodal Treatment With Extrapleural Pneumonectomy for Female Epithelioid Malignant Pleural Mesothelioma. Journal of Thoracic Oncology.
• Ossowski, S. et al. (2021, October 1). Improving Outcomes in Malignant Pleural Mesothelioma in an Integrated Health System. Journal of Thoracic Oncology.
• Ely, S. et al. (2021, March 19). Effect of thoracic surgery regionalization on long-term survival after lung cancer resection. The Journal of Thoracic and Cardiovascular Surgery.
• Ely, S. et al. (2020, March 14). Regionalization of Lung Cancer Surgery Improves Outcomes in an Integrated Health Care System. The Annals of Thoracic Surgery.

Dr. Jeffrey Velotta Videos

Previous NextNext Video

Exclusive Content

Dr. Jeffrey Velotta: Why do you collaborate with Asbestos.com

Expert Take

Dr. Jeffrey Velotta: Dr. Jeffrey Velotta is interviewed about this rare cancer